TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P14
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -10.03% |
| Q3 2025 | 5.29% |
| Q2 2025 | 9.53% |
| Q1 2025 | 0.33% |
| Q4 2024 | 7.37% |
| Q3 2024 | 9.09% |
| Q2 2024 | -11.97% |
| Q1 2024 | -2.62% |
| Q4 2023 | -15.28% |
| Q3 2023 | 63.50% |
| Q2 2023 | 23.33% |
| Q1 2023 | -14.07% |
| Q4 2022 | 21.30% |
| Q3 2022 | 15.22% |
| Q2 2022 | 10.65% |
| Q1 2022 | 13.78% |
| Q4 2021 | 457.19% |
| Q3 2021 | 2.98% |
| Q2 2021 | 154.53% |
| Q1 2021 | 183.88% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |